Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 02, 2026 1.302B
October 01, 2026 1.325B
September 30, 2026 1.360B
September 29, 2026 1.361B
September 28, 2026 1.358B
September 25, 2026 1.330B
September 24, 2026 1.325B
September 23, 2026 1.317B
September 22, 2026 1.363B
September 21, 2026 1.294B
September 18, 2026 1.244B
September 17, 2026 1.226B
September 16, 2026 1.119B
September 15, 2026 1.099B
September 14, 2026 1.159B
September 11, 2026 1.131B
September 10, 2026 1.111B
September 09, 2026 1.201B
September 08, 2026 1.257B
September 04, 2026 1.262B
September 03, 2026 1.282B
September 02, 2026 1.279B
September 01, 2026 1.246B
August 31, 2026 1.122B
August 28, 2026 1.104B
Date Value
August 27, 2026 1.070B
August 26, 2026 1.096B
August 25, 2026 1.134B
August 24, 2026 1.038B
August 21, 2026 1.051B
August 20, 2026 965.73M
August 19, 2026 1.027B
August 18, 2026 884.97M
August 17, 2026 908.04M
August 14, 2026 904.74M
August 13, 2026 919.58M
August 12, 2026 889.91M
August 11, 2026 888.26M
August 10, 2026 878.37M
August 07, 2026 888.26M
August 06, 2026 853.65M
August 05, 2026 847.06M
August 04, 2026 840.47M
August 03, 2026 799.26M
July 31, 2026 784.43M
July 30, 2026 804.21M
July 29, 2026 787.72M
July 28, 2026 792.67M
July 27, 2026 812.45M
July 24, 2026 807.50M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Merck & Co., Inc. 403.00B
Pfizer Inc. 210.23B
Agenus, Inc. 620.93M
Editas Medicine, Inc. 261.86M
Recursion Pharmaceuticals, Inc. 1.716B